Analyst picks & changes

Genzyme Corp.

(GENZ)

Business: Biopharmaceuticals

Michael Ehrenreich of Ehrenreich & Co. said GENZ had a very strong second quarter, driven by revenue growth in

Ceredase

Read the full 263 word article

How to gain access

Continue reading with a
two-week free trial.